tirzepatide vs. semaglutide for weight loss vs side effects nausea Semaglutide Tirzepatide – Which Shot Fits You Best? Tirzepatide vs Semaglutide for Weight
Description
Similarly, the 2020 guidelines of the American Association of Clinical Endocrinologists 44 recommend long-acting GLP-1 receptor agonists or SGLT-2 inhibitors in patients with type 2 diabetes and established or high risk of atherosclerotic cardiovascular disease with or without chronic kidney disease, regardless of glycemic control

Dizziness is a broad term that covers feeling lightheaded, faint, or unsteady on your feet

Metformin and insulin were the established treatments for T2D in youth until the recent approval by the Food and Drug Administration (FDA) of two SGLT2 inhibitors (dapagliflozin and empagliflozin) for children and adolescents above 10 years of age with T2D, for use in combination with diet and exercise

Insomnia is not listed among common adverse reactions in FDA prescribing information, and clinical trials did not identify it as a statistically significant side effect

It's important to remember that we're talking about a compound that interacts directly with the body's intricate endocrine system

It could be a sign of an underlying condition that needs treatment
